Medindia

X

NPIL withdraws Parkinsonís drug

by Medindia Content Team on  October 20, 2001 at 11:43 AM Drug News   - G J E 4
NPIL withdraws Parkinsonís drug
It has been reportedly said that Nicholas Piramal India Ltd which imports the raw material and manufactures Madopar, Parkinson's drug, locally has ceased its production in both vial and tablet form following price control.
Advertisement

The company had approached the National Pharmaceutical Pricing Authority (NPPA) to reconsider its price revision. However, according to NPPA sources the cased was already ''pending review'' with the Ministry of Chemicals and Fertilisers.

Advertisement
According to NPPA sources the 10 tablet strips came under the price control which the company launched after the price control on vials. The existing MRP of a 10 tablet strip of 250 mg was Rs 56, whereas the company was seeking an MRP of Rs 97.84 to make it viable for the company.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All